These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19367145)

  • 21. Chronic heart failure: current evidence, challenges to therapy, and future directions.
    Morrissey RP; Czer L; Shah PK
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):153-71. PubMed ID: 21619379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
    Zile MR; Bennett TD; St John Sutton M; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Stevenson LW; Kueffer FJ; Bourge RC
    Circulation; 2008 Sep; 118(14):1433-41. PubMed ID: 18794390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical advances in diastolic heart failure.
    McManus D; Aurigemma G
    Minerva Cardioangiol; 2006 Dec; 54(6):695-713. PubMed ID: 17167382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular geometry, risk factors, and outcomes of hospitalized patients with diastolic heart failure in Japan.
    Uchino K; Ishigami T; Ohshige K; Sugano T; Ishikawa T; Kimura K; Umemura S
    J Cardiol; 2009 Aug; 54(1):101-7. PubMed ID: 19632528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current controversies in heart failure with a preserved ejection fraction.
    MacIver DH
    Future Cardiol; 2010 Jan; 6(1):97-111. PubMed ID: 20014990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH; Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The other side of heart failure.
    Johns Hopkins Med Lett Health After 50; 2009 Aug; 21(6):4-5. PubMed ID: 19722311
    [No Abstract]   [Full Text] [Related]  

  • 28. Diastolic heart failure in elderly: the prognostic factors and interventions regarding heart failure with preserved ejection fraction.
    Acikel S; Akdemir R; Kilic H; Yesilay AB; Dogan M; Cagirci G
    Int J Cardiol; 2010 Feb; 138(3):311-3. PubMed ID: 18845346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of diabetes and hypertension on the heart.
    Pieske B; Wachter R
    Curr Opin Cardiol; 2008 Jul; 23(4):340-9. PubMed ID: 18520718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure in women: epidemiology, biology and treatment.
    Shah RU; Klein L; Lloyd-Jones DM
    Womens Health (Lond); 2009 Sep; 5(5):517-27. PubMed ID: 19702451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heart failure with preserved ejection fraction: Diastolic heart failure].
    Rutten FH; Cramer MJ; Paulus WJ
    Ned Tijdschr Geneeskd; 2012; 156(45):A5315. PubMed ID: 23134752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance.
    McDonald K
    Int J Cardiol; 2008 Apr; 125(2):197-202. PubMed ID: 18160154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.
    Campbell RT; McMurray JJ
    Heart Fail Clin; 2014 Jul; 10(3):481-501. PubMed ID: 24975911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure.
    Gorelik O; Almoznino-Sarafian D; Shteinshnaider M; Alon I; Tzur I; Sokolsky I; Efrati S; Babakin Z; Modai D; Cohen N
    Clin Res Cardiol; 2009 Apr; 98(4):224-32. PubMed ID: 19219395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014).
    Lemor A; Hernandez GA; Lee S; Patel N; Blumer V; Badiye A; Alfonso C; Fonarow GC; Lindenfeld J; Chaparro S
    Int J Cardiol; 2018 Sep; 266():174-179. PubMed ID: 29887443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts in diastolic heart failure.
    Dhar S; Koul D; D'Alonzo GE
    J Am Osteopath Assoc; 2008 Apr; 108(4):203-9. PubMed ID: 18443028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure.
    Zareba KM; Shenkman HJ; Bisognano JD
    Congest Heart Fail; 2009; 15(4):165-9. PubMed ID: 19627289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure.
    Tada T; Shiba N; Watanabe J; Matsuki M; Kagaya Y; Shinozaki T; Shirato K; Shimokawa H
    Int J Cardiol; 2008 Aug; 128(3):419-21. PubMed ID: 17643528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients.
    Tang ZH; Wang L; Zeng F; Zhang K
    BMC Cardiovasc Disord; 2014 Sep; 14():124. PubMed ID: 25249273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.